ACTIVE SUBSTANCE / INN

GRANISETRON

Brand name(s): SANCUSO, Sancuso, SUSTOL
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Vomiting;Cancer
NDA022445
ACTIVE SUBSTANCE
Granisetron
REGULATORS
FDA · EMA
SPONSORS / MAH
Grünenthal GmbH, CUMBERLAND, HERON THERAPS INC
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SUSTOLNDA022445HERON THERAPS INCPrescription
SANCUSONDA022198CUMBERLANDPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
SancusoGrünenthal GmbHAuthorised20/04/2012Vomiting;Cancer

FULL INTELLIGENCE ON GRANISETRON

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →